Our client has developed a revolutionary therapy that focuses on accelerating the deployment of novel biotherapeutics targeting urgent microbial challenges in human health and beyond. They are engineering viruses that ultimately kill antibiotic resistant bacteria (bacteriophages). They are currently seeking their Series A funding and are looking for a Chief Medical Officer to join their team. This position can sit anywhere in the US (remote).
Nov 06, 2020